Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Osteoblastoma D018215 1 associated lipids
Erythromelalgia D004916 1 associated lipids
Fibromuscular Dysplasia D005352 2 associated lipids
Atrial Premature Complexes D018880 1 associated lipids
Latex Hypersensitivity D020315 1 associated lipids
Drowning D004332 2 associated lipids
Jejunal Diseases D007579 3 associated lipids
Basal Ganglia Hemorrhage D020145 1 associated lipids
Radiculopathy D011843 1 associated lipids
Intracranial Hemorrhage, Hypertensive D020299 1 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Tsukamoto H et al. Simultaneous quantification of prostaglandins, isoprostane and thromboxane in cell-cultured medium using gas chromatography-mass spectrometry. 2002 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:12076690
Jung K et al. The effect of dietary intervention through the modification of fatty acids composition and antioxidant vitamin intake on plasma TXB(2) level in Korean postmenopausal women with hypercholesterolemia. 2002 J. Korean Med. Sci. pmid:12068132
Jung YS et al. Antithrombotic effect of onion in streptozotocin-induced diabetic rat. 2002 Prostaglandins Leukot. Essent. Fatty Acids pmid:12054917
van Kraaij DJ et al. A comparison of the effects of nabumetone vs meloxicam on serum thromboxane B2 and platelet function in healthy volunteers. 2002 Br J Clin Pharmacol pmid:12047490
Sakai H et al. E3040 sulphate, a novel thromboxane synthase inhibitor, blocks the Cl- secretion induced by platelet-activating factor in isolated rat colon. 2002 Br. J. Pharmacol. pmid:12023941
Yan C and Feng Y [Effects of butylphthalide on extracellular 6-keto-PGF1 alpha, TXB2 and 6-keto-PGF1 alpha/TXB2 ratio in cultured rat cortical neurons]. 1998 Yao Xue Xue Bao pmid:12016850
Nakamura H et al. Difference in urinary 11-dehydro TXB2 and LTE4 excretion in patients with rheumatoid arthritis. 2001 Nov-Dec Prostaglandins Leukot. Essent. Fatty Acids pmid:11993724
Jeng JH et al. Modulation of platelet aggregation by areca nut and betel leaf ingredients: roles of reactive oxygen species and cyclooxygenase. 2002 Free Radic. Biol. Med. pmid:11978487
Hayashi M et al. The levels of five markers of hemostasis and endothelial status at different stages of normotensive pregnancy. 2002 Acta Obstet Gynecol Scand pmid:11966476
Knijff-Dutmer EA et al. Platelet function is inhibited by non-selective non-steroidal anti-inflammatory drugs but not by cyclo-oxygenase-2-selective inhibitors in patients with rheumatoid arthritis. 2002 Rheumatology (Oxford) pmid:11961179
Wainwright CL et al. NCX4016 (NO-aspirin) reduces infarct size and suppresses arrhythmias following myocardial ischaemia/reperfusion in pigs. 2002 Br. J. Pharmacol. pmid:11959790
Burleigh ME et al. Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice. 2002 Circulation pmid:11956125
Hu X et al. [The influence of nasal continual positive airway pressure on some vasoactive substances in patients with obstructive sleep apnea syndrome]. 2002 Zhonghua Jie He He Hu Xi Za Zhi pmid:11953098
Signorello MG et al. Effect of homocysteine on arachidonic acid release in human platelets. 2002 Eur. J. Clin. Invest. pmid:11952814
Huang K et al. Role of selenium in cytoprotection against cholesterol oxide-induced vascular damage in rats. 2002 Atherosclerosis pmid:11947907
Eikelboom JW et al. Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. 2002 Circulation pmid:11940542
Yu W and Xu L [Effects of acetylsalvianolic acid A on arachidonic acid metabolism in platelets]. 1998 Yao Xue Xue Bao pmid:11938938
Miao X et al. [Effect of yinchen dandao decoction on plasma fibronectin, biliary thromboxane A2 and prostaglandin I2 in human and animal suffering from acute cholangitis]. 2000 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:11938860
Shi X et al. [Effects of Salvia miltiorrhiza compound injection on serum endothelin, prostaglandin I2/thromboxane A2 ratio alteration following myocardial ischemia-reperfusion in patients undergoing intracardiac surgery]. 2000 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:11938858
Yu K et al. [Clinical observation on treatment of pediatric intractable nephropathy with modified taohong siwu decoction]. 2000 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:11938829
Wang Z et al. [Clinical and experimental study on treatment of bronchial asthma with pingchuan oral liquid]. 2000 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:11938808
Yamasaki M et al. No involvement of interleukin-5 or eosinophils in experimental allergic rhinitis in guinea pigs. 2002 Eur. J. Pharmacol. pmid:11937106
Oelz O [The arachidonic acid metabolites (prostaglandins, thromboxanes, prostacyclin, leucotrienes):basics and clinical implications (author's transl)]. 1979 Ther Umsch pmid:119331
Giardiello FM et al. Primary chemoprevention of familial adenomatous polyposis with sulindac. 2002 N. Engl. J. Med. pmid:11932472
Miyataka M et al. Nitric oxide, anti-inflammatory drugs on renal prostaglandins and cyclooxygenase-2. 2002 Hypertension pmid:11897764
Venuto R et al. Enhanced vascular effects of the Ca(2+) channel agonist Bay K 8644 in pregnant rabbits. 2002 Am. J. Physiol. Regul. Integr. Comp. Physiol. pmid:11893597
Lassus P et al. Pulmonary prostacyclin is associated with less severe respiratory distress in preterm infants. 2002 Early Hum. Dev. pmid:11893431
Feng TC et al. Effect of valsartan and captopril in rabbit carotid injury. Possible involvement of bradykinin in the antiproliferative action of the renin-angiotensin blockade. 2001 J Renin Angiotensin Aldosterone Syst pmid:11881060
Küsters S et al. Effects of antihistamines on leukotriene and cytokine release from dispersed nasal polyp cells. 2002 Arzneimittelforschung pmid:11878205
Sheu JR et al. Mechanisms involved in the antiplatelet activity of midazolam in human platelets. 2002 Anesthesiology pmid:11873041
Kiemer AK et al. Inhibition of cyclooxygenase-2 by natriuretic peptides. 2002 Endocrinology pmid:11861506
Ma LP et al. Inhibition of platelet aggregation and expression of alpha granule membrane protein 140 and thromboxane B2 with pravastatin therapy for hypercholesterolemia. 2002 J Assoc Acad Minor Phys pmid:11852667
Ochi T and Goto T Differential effect of FR122047, a selective cyclo-oxygenase-1 inhibitor, in rat chronic models of arthritis. 2002 Br. J. Pharmacol. pmid:11834626
Leahy KM et al. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. 2002 Cancer Res. pmid:11830509
Xing X et al. [Preserving remnant liver function after major hepatic vein occlusion]. 1998 Zhonghua Wai Ke Za Zhi pmid:11825430
Bermejo BP et al. Sesquiterpenes from Jasonia glutinosa: in vitro anti-inflammatory activity. 2002 Biol. Pharm. Bull. pmid:11824534
Zhang LH et al. Effects of extract F of red-rooted Salvia on mucosal lesions of gastric corpus and antrum induced by hemorrhagic shock-reperfusion in rats. 2001 World J. Gastroenterol. pmid:11819852
Bayorh MA et al. 1A-779 attenuates angiotensin-(1-7) depressor response in salt-induced hypertensive rats. 2002 Peptides pmid:11814618
Connolly E et al. Cyclooxygenase isozyme expression and intimal hyperplasia in a rat model of balloon angioplasty. 2002 J. Pharmacol. Exp. Ther. pmid:11805196
Canbaz M et al. Effects of tibolone on thromboxane B(2) levels in postmenopausal women. 2002 Gynecol. Obstet. Invest. pmid:11803222
Obase Y et al. Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients. 2002 Chest pmid:11796443
Huang F et al. Anti-platelet and anti-thrombotic effects of triacetylshikimic acid in rats. 2002 J. Cardiovasc. Pharmacol. pmid:11791012
Han G et al. [Inhibitory effect of panicoin on platelet activation and its mechanism]. 2000 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:11789213
Xu L et al. [Clinical and experimental study on effect of Chanbei Kechuanping in treating bronchial asthma]. 2000 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:11789166
Ochi T and Goto T Anti-inflammatory activity of a novel selective cyclooxygenase-2 inhibitor, FR140423, on type II collagen-induced arthritis in Lewis rats. 2001 Prostaglandins Other Lipid Mediat. pmid:11785783
Hu Z et al. [Experimental study of influence of yiqi huoxue serial recipes on basement membrane in membranous nephritis in rabbits]. 1999 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:11783306
Zhou X et al. [Clinical and experimental study on effect of Shuguan granule on mid-late rheumatoid arthritis]. 1999 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:11783301
Wang S et al. [Effects of ligustrazine on plasma platelet aggregation rate, thromboxane B2, 6-keto-prostaglandin F1 alpha and von Willebrand's factor in patients with acute onset of cor pulmonale]. 1999 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:11783174
Best LC et al. Evidence that extracellular calcium ions inhibit thromboxane B2 biosynthesis by human platelets. 1979 Biochem. Biophys. Res. Commun. pmid:117802
Bruno A et al. Aspirin and urinary 11-dehydrothromboxane B(2) in African American stroke patients. 2002 Stroke pmid:11779889
Heng W et al. [The role of platelet activation in the pathogenesis of asthma]. 2000 Zhonghua Jie He He Hu Xi Za Zhi pmid:11778515
Dong Y et al. [Quantitive study of 6-keto-prostaglandin F1 alpha and thromboxane B2 in human pulp]. 1999 Zhonghua Kou Qiang Yi Xue Za Zhi pmid:11776916
Zhou L et al. [The effect of plasma from women with preeclampsia on endothelial cells activators in vitro]. 2000 Zhonghua Fu Chan Ke Za Zhi pmid:11776183
Chen J et al. [Study on the relationship between the bond absorption of chronic periapical periodontitis and PGE2 and TXB2]. 1998 Zhonghua Kou Qiang Yi Xue Za Zhi pmid:11774418
Catella-Lawson F et al. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. 2001 N. Engl. J. Med. pmid:11752357
Kurokawa K et al. Circadian characteristics of urinary leukotriene E(4) in healthy subjects and nocturnal asthmatic patients. 2001 Chest pmid:11742908
Domoki F et al. Cyclooxygenase-2 inhibitor NS398 preserves neuronal function after hypoxia/ischemia in piglets. 2001 Neuroreport pmid:11742239
Gao YJ and Lee RM Hydrogen peroxide induces a greater contraction in mesenteric arteries of spontaneously hypertensive rats through thromboxane A(2) production. 2001 Br. J. Pharmacol. pmid:11739239
Stichtenoth DO et al. Effects of intravenous oxygen on prostacyclin and thromboxane formation in patients with peripheral occlusive arterial disease. 2001 Prostaglandins Leukot. Essent. Fatty Acids pmid:11728174
Hishinuma T et al. Relationship between thromboxane/prostacyclin ratio and diabetic vascular complications. 2001 Prostaglandins Leukot. Essent. Fatty Acids pmid:11728171
Goulet JL et al. Deficiency of 5-lipoxygenase accelerates renal allograft rejection in mice. 2001 J. Immunol. pmid:11714834
Bing RJ et al. Nitric oxide, prostanoids, cyclooxygenase, and angiogenesis in colon and breast cancer. 2001 Clin. Cancer Res. pmid:11705852
Mita H et al. Possible involvement of mast-cell activation in aspirin provocation of aspirin-induced asthma. 2001 Allergy pmid:11703219
Brideau C et al. In vitro effects of cyclooxygenase inhibitors in whole blood of horses, dogs, and cats. 2001 Am. J. Vet. Res. pmid:11703020
Ferlito M et al. Effect of cross-tolerance between endotoxin and TNF-alpha or IL-1beta on cellular signaling and mediator production. 2001 J. Leukoc. Biol. pmid:11698503
Kitamura R et al. Thiopental enhances human platelet aggregation by increasing arachidonic acid release. 2001 Can. J. Physiol. Pharmacol. pmid:11697744
Dionne RA et al. Analgesia and COX-2 inhibition. 2001 Nov-Dec Clin. Exp. Rheumatol. pmid:11695255
Wang WJ and Huang TF A novel tetrameric venom protein, agglucetin from Agkistrodon acutus, acts as a glycoprotein Ib agonist. 2001 Thromb. Haemost. pmid:11686327
Wang ZY et al. Comparative study of platelet activation markers in diabetes mellitus patients complicated by cerebrovascular disease. 2001 Blood Coagul. Fibrinolysis pmid:11685040
Wan Y et al. Effects of cocoa powder and dark chocolate on LDL oxidative susceptibility and prostaglandin concentrations in humans. 2001 Am. J. Clin. Nutr. pmid:11684527
McConnell JP et al. Urinary 11-dehydro-thromboxane B(2) and coagulation activation markers measured within 24 h of human acute ischemic stroke. 2001 Neurosci. Lett. pmid:11684346
Gloor B et al. Hydrocortisone treatment of early SIRS in acute experimental pancreatitis. 2001 Dig. Dis. Sci. pmid:11680590
Nüsing RM et al. Pathogenetic role of cyclooxygenase-2 in hyperprostaglandin E syndrome/antenatal Bartter syndrome: therapeutic use of the cyclooxygenase-2 inhibitor nimesulide. 2001 Clin. Pharmacol. Ther. pmid:11673754
Ziegler BK et al. Incomplete thromboxane inhibition with 100 mg of intravenous acetylsalicylic acid in patients with acute ST elevation myocardial infarction: a placebo-controlled pilot trial. 2001 Thromb. Res. pmid:11672759
Watanabe T et al. Enhanced platelet sensitivity to prostacyclin in patients in an active stage of Takayasu arteritis. 2001 Thromb. Res. pmid:11672751
Okuma M and Uchino H Altered arachidonate metabolism by platelets in patients with myeloproliferative disorders. 1979 Blood pmid:116695
Wong PY and Cheung WY Calmodulin stimulates human platelet phospholipase A2. 1979 Biochem. Biophys. Res. Commun. pmid:116656
Tubaro E et al. Anti-inflammatory and antiplatelet effects of amtolmetin guacyl, a new gastroprotective non-steroidal anti-inflammatory drug. 2001 Arzneimittelforschung pmid:11642006
Galipeau D et al. Chronic thromboxane synthase inhibition prevents fructose-induced hypertension. 2001 Hypertension pmid:11641301
Haastrup A et al. Lipids stimulate the production of 6-keto-prostaglandin f(1alpha) in human dorsal hand veins. 2001 Hypertension pmid:11641299
Minuz P et al. NCX4016 (NO-Aspirin) has multiple inhibitory effects in LPS-stimulated human monocytes. 2001 Br. J. Pharmacol. pmid:11606332
Sunose Y et al. Effect of a cyclooxygenase-2 inhibitor, FK3311, in a canine lung transplantation model. 2001 Ann. Thorac. Surg. pmid:11603431
Cyrus T et al. Lipid peroxidation and platelet activation in murine atherosclerosis. 2001 Circulation pmid:11602498
Lu G et al. [Effect of xueling on relating substances of renal hypertension in rats]. 1998 Zhongguo Zhong Yao Za Zhi pmid:11601304
Duan M et al. Factors involved in the neuronal death during postischemic reperfusion: experimental study in rabbits. 1999 Chin. Med. J. pmid:11593584
Llinás MT et al. Role of COX-2-derived metabolites in regulation of the renal hemodynamic response to norepinephrine. 2001 Am. J. Physiol. Renal Physiol. pmid:11592955
Jilma-Stohlawetz P et al. Impaired platelet function among platelet donors. 2001 Thromb. Haemost. pmid:11583322
Van Solingen RM et al. Comparison of the effects of ketoprofen on platelet function in the presence and absence of aspirin. 2001 Am. J. Med. pmid:11566459
Martinuzzo ME et al. Increased lipid peroxidation correlates with platelet activation but not with markers of endothelial cell and blood coagulation activation in patients with antiphospholipid antibodies. 2001 Br. J. Haematol. pmid:11564073
Blann AD et al. Changes in endothelial, leucocyte and platelet markers following contrast medium injection during angiography in patients with peripheral artery disease. 2001 Br J Radiol pmid:11560828
Oketani K et al. Effect of E3040, an inhibitor of 5-lipoxygenase and thromboxane synthase, on rat bowel damage induced by lipopolysaccharide. 2001 Eur. J. Pharmacol. pmid:11557269
Kaaja R et al. Increased thromboxane production in women with a history of venous thromboembolic event: effect of heparins. 2001 Br. J. Haematol. pmid:11552994
Broulík PD et al. Impact of antihypertensive therapy on the skeleton: effects of enalapril and AT1 receptor antagonist losartan in female rats. 2001 Physiol Res pmid:11551140
Giese A et al. Thromboxane synthase regulates the migratory phenotype of human glioma cells. 1999 Neuro-oncology pmid:11550298
Beck-Speier I et al. Agglomerates of ultrafine particles of elemental carbon and TiO2 induce generation of lipid mediators in alveolar macrophages. 2001 Environ. Health Perspect. pmid:11544173
Alcaraz A et al. Experimental kidney transplantation in pigs from non-heart-beating donors: evaluation of vasoactive substances and renal artery flow. 2001 Transplant. Proc. pmid:11543815
Li F et al. [Effects of frostbite on some factors of blood coagulation system in rats under hypoxia]. 1996 Space Med Med Eng (Beijing) pmid:11539914
Davì G et al. Oxidative stress and platelet activation in homozygous homocystinuria. 2001 Circulation pmid:11535567
Patrono C et al. Inhibition of platelet cyclooxygenase by aspirin-like drugs: methods for in vitro and ex vivo assessment. 1979 Agents Actions Suppl. pmid:115255
Fritsma GA et al. Monitoring the antiplatelet action of aspirin. 2001 JAAPA pmid:11523339